Drawing for MAGNETOFECTION

USPTO serial 79182650

MAGNETOFECTION

Reviewed by CopyMark Law Group

Reg. 5116540Status 739Renewal
Filing date
Status date
Registration date
Jan 10, 2017
Examiner
STRUCK, ROBERT J
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with MAGNETOFECTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Neil A. Salyards

Neil A. Salyards Procopio Cory Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science, photographic chemicals, chemicals used in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; chemical reagents other than for medical or veterinary use; biochemical, chemical and biological diagnostic reagents for use in scientific research, in industry and science; chemical, biochemical and biological products for scientific, medical or pharmaceutical research, namely, reagents, vaccine adjuvants, nucleic acids, stem cells, protein arrays, and assays for research puroposesACTIVE—
005Pharmaceutical and veterinary preparations for the development of vaccines and for the prevention and treatment of diseases and disorders of the body and the mind, namely, for the skeletal, muscular, nervous, endocrine, immune, circulatory, hematological, cardiovascular, cardiopulmonary, lymphatic, respiratory, digestive, genitourinary, urinary, reproductive, psychiatric, metabolic, oncological, hepatological, ophthalmic, neurological, gastrointestinal, hormonal and integumentary systems and hormonal, oncological, and pain relief preparations, and diagnostic products for medical purposes; sanitary preparations for medical purposes; gauze for dressings; material for dental fillings and dental impressions; disinfectants; bath preparations for medical use; sanitary panties and napkins; chemical preparations for the development of vaccines and for the prevention and treatment of diseases and disorders of the body and the mind, namely, for the skeletal, muscular, nervous, endocrine, immune, circulatory, hematological, cardiovascular, cardiopulmonary, lymphatic, respiratory, digestive, genitourinary, urinary, reproductive, psychiatric, metabolic, oncological, hepatological, ophthalmic, neurological, gastrointestinal, hormonal and integumentary systems and hormonal, oncological, and pain relief preparations, and diagnostic products for medical or pharmaceutical use; medicinal herbs; herbal teas for medical purposes; alloys of precious metals for dental use; chemical, biochemical and biological preparations for medical or pharmaceutical use, namely, reagents, vaccine adjuvants, nucleic acids, stem cells, protein arrays, and assays for medical or pharmaceutical purposesACTIVE—
042Evaluations and assessments in the fields of science and technology provided by engineers, namely, consulting in the field of engineering; scientific research; research and development of new products for others; technical project studies, namely, scientific research and development; scientific research for medical purposes; research and development of new products for applications in life sciences, in the pharmaceutical, parapharmaceutical and veterinary fields; research in biology, bacteriology, chemistry, cosmetology and physicsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026ES71TEAS SECTION 71 RECEIVED—
Oct 21, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 10, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 22, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 24, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 18, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 7, 2023NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Aug 6, 2023C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 6, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 19, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Jan 10, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 28, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 11, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 11, 2017FIMPFINAL DISPOSITION PROCESSED—
Apr 10, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 3, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2016ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 23, 2016CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Nov 22, 2016APETASSIGNED TO PETITION STAFF—
Nov 4, 2016EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 14, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 20, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 17, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 9, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 14, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 14, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 14, 2016ALIEASSIGNED TO LIE—
Jul 8, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 19, 2016RFNTREFUSAL PROCESSED BY IB—
Mar 3, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 3, 2016RFRRREFUSAL PROCESSED BY MPU—
Mar 3, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 2, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2016DOCKASSIGNED TO EXAMINER—
Feb 24, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance